Journal
CANCER CELL
Volume 22, Issue 2, Pages 145-152Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2012.06.031
Keywords
-
Categories
Funding
- Italian Association for Cancer Research (AIRC) [IG-11598]
- International Association for Cancer Research (AICR-UK) [11-0274]
- Italian Ministry for Research (PRIN)
- Worldwide Cancer Research [11-0274] Funding Source: researchfish
Ask authors/readers for more resources
Semaphorins are mainly known as guidance signals in development, acting through receptors called Plexins. However, their role in cancer is rapidly emerging in the regulation of tumor angiogenesis, tumor growth, cancer cell invasiveness, and metastatic spreading. Intriguingly, activated plexins can transactivate receptor tyrosine kinases, such as MET, VEGFR2, FGFR2, and ERBB2, and lead to distinctive effects in a cell-context-dependent manner. Moreover, certain semaphorins concomitantly target endothelial and cancer cells, and can achieve remarkable inhibition of angiogenesis and tumor growth, associated with anti-metastatic activity. Altogether, these data validate the identification of semaphorin signals as promising therapeutic targets in cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available